These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38558411)

  • 1. Reverse-engineered exclusive enteral nutrition in pediatric Crohn's disease: A pilot trial.
    Lee D; Braly K; Nuding M; Braly I; Hopp C; Twible H; Pope C; Hayden HS; Hoffman L; Zheng H; Wahbeh G; Suskind DL
    J Pediatr Gastroenterol Nutr; 2024 May; 78(5):1135-1142. PubMed ID: 38558411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial Taxa and Functions Are Predictive of Sustained Remission Following Exclusive Enteral Nutrition in Pediatric Crohn's Disease.
    Jones CMA; Connors J; Dunn KA; Bielawski JP; Comeau AM; Langille MGI; Van Limbergen J
    Inflamm Bowel Dis; 2020 Jun; 26(7):1026-1037. PubMed ID: 31961432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial.
    Levine A; Wine E; Assa A; Sigall Boneh R; Shaoul R; Kori M; Cohen S; Peleg S; Shamaly H; On A; Millman P; Abramas L; Ziv-Baran T; Grant S; Abitbol G; Dunn KA; Bielawski JP; Van Limbergen J
    Gastroenterology; 2019 Aug; 157(2):440-450.e8. PubMed ID: 31170412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial enteral nutrition induces clinical and endoscopic remission in active pediatric Crohn's disease: results of a prospective cohort study.
    Urlep D; Benedik E; Brecelj J; Orel R
    Eur J Pediatr; 2020 Mar; 179(3):431-438. PubMed ID: 31781933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Active Crohn's Disease With an Ordinary Food-based Diet That Replicates Exclusive Enteral Nutrition.
    Svolos V; Hansen R; Nichols B; Quince C; Ijaz UZ; Papadopoulou RT; Edwards CA; Watson D; Alghamdi A; Brejnrod A; Ansalone C; Duncan H; Gervais L; Tayler R; Salmond J; Bolognini D; Klopfleisch R; Gaya DR; Milling S; Russell RK; Gerasimidis K
    Gastroenterology; 2019 Apr; 156(5):1354-1367.e6. PubMed ID: 30550821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of exclusive enteral nutrition on the gut microbiome and bile acid metabolism in pediatric Crohn's disease.
    Lv Y; Lou Y; Liu A; Cheng Q; Yang G; Xu C; Luo Y; Lou J; Yu J; Fang Y; Zhao H; Peng K; Ni Y; Chen J
    Clin Nutr; 2023 Feb; 42(2):116-128. PubMed ID: 36527826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formula modifications to the Crohn's disease exclusion diet do not impact therapy success in paediatric Crohn's disease.
    Landorf E; Hammond P; Abu-Assi R; Ellison S; Boyle T; Comerford A; Couper R
    J Pediatr Gastroenterol Nutr; 2024 Jun; 78(6):1279-1286. PubMed ID: 38623960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of an adalimumab combined with partial enteral nutrition in the induction period of Crohn's disease.
    Zhou S; Huang Z; Hou W; Lin Y; Yu J
    Inflamm Res; 2024 Feb; 73(2):199-209. PubMed ID: 38168701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal calprotectin is not a clinically useful marker for the prediction of the early nonresponse to exclusive enteral nutrition in pediatric patients with Crohn disease.
    Copova I; Hradsky O; Zarubova K; Gonsorcikova L; Potuznikova K; Lerchova T; Nevoral J; Bronsky J
    Eur J Pediatr; 2018 Nov; 177(11):1685-1693. PubMed ID: 30128744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: a feasible and effective approach.
    Day AS; Whitten KE; Lemberg DA; Clarkson C; Vitug-Sales M; Jackson R; Bohane TD
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1609-14. PubMed ID: 16928225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Effectiveness of Nutritional and Biological Therapy in North American Children with Active Crohn's Disease.
    Lee D; Baldassano RN; Otley AR; Albenberg L; Griffiths AM; Compher C; Chen EZ; Li H; Gilroy E; Nessel L; Grant A; Chehoud C; Bushman FD; Wu GD; Lewis JD
    Inflamm Bowel Dis; 2015 Aug; 21(8):1786-93. PubMed ID: 25970545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial.
    Yanai H; Levine A; Hirsch A; Boneh RS; Kopylov U; Eran HB; Cohen NA; Ron Y; Goren I; Leibovitzh H; Wardi J; Zittan E; Ziv-Baran T; Abramas L; Fliss-Isakov N; Raykhel B; Gik TP; Dotan I; Maharshak N
    Lancet Gastroenterol Hepatol; 2022 Jan; 7(1):49-59. PubMed ID: 34739863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Exclusive Enteral Nutrition on the Disease Process, Nutrition Status, and Gastrointestinal Microbiota for Chinese Children With Crohn's Disease.
    Tang W; Huang Y; Shi P; Wang Y; Zhang Y; Xue A; Tang Z; Hu W; Sun H; Zhang P; Zheng C; Shi J; Wang S; Qiu X; Lu X; Miao S; Meng Y
    JPEN J Parenter Enteral Nutr; 2021 May; 45(4):826-838. PubMed ID: 32510616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn's disease.
    Ong C; Lim PT; Logarajah V; Liwanag MJ; Ang BX; Cher Y; Chiou FK; Kader A
    BMC Gastroenterol; 2018 Dec; 18(1):185. PubMed ID: 30541458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Exclusive enteral nutrition continues to be first line therapy for pediatric Crohn's disease in the era of biologics].
    Navas-López VM; Blasco-Alonso J; Lacasa Maseri S; Girón Fernández-Crehuet F; Serrano Nieto MJ; Vicioso Recio MI; Sierra Salinas C
    An Pediatr (Barc); 2015 Jul; 83(1):47-54. PubMed ID: 24704330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Mucosal Healing with Exclusive Enteral Nutrition is Associated with Improved Outcomes in Newly Diagnosed Children with Luminal Crohn's disease.
    Grover Z; Burgess C; Muir R; Reilly C; Lewindon PJ
    J Crohns Colitis; 2016 Oct; 10(10):1159-64. PubMed ID: 26980840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral exclusive enteral nutrition for induction of clinical remission, mucosal healing, and improvement of nutritional status and growth velocity in children with active Crohn's disease - a prospective multicentre trial.
    Matuszczyk M; Meglicka M; Landowski P; Czkwianianc E; Sordyl B; Szymańska E; Kierkuś J
    Prz Gastroenterol; 2021; 16(4):346-351. PubMed ID: 34976243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial fecal calprotectin changes in children with Crohn's disease on treatment with exclusive enteral nutrition: associations with disease activity, treatment response, and prediction of a clinical relapse.
    Gerasimidis K; Nikolaou CK; Edwards CA; McGrogan P
    J Clin Gastroenterol; 2011 Mar; 45(3):234-9. PubMed ID: 20871409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the Crohn's Disease Exclusion Diet (CDED) on the Fecal Calprotectin Level in Children with Active Crohn's Disease.
    Matuszczyk M; Meglicka M; Wiernicka A; Jarzębicka D; Osiecki M; Kotkowicz-Szczur M; Kierkuś J
    J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of induction therapy with exclusive enteral nutrition in pediatric Crohn's disease].
    Luo YY; Fang YH; Yu JD; Xu LJ; Sun MF; Cheng Q; Chen J
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jun; 24(6):626-630. PubMed ID: 35762427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.